Precursor B-cell lymphoblastic lymphoma in childhood and adolescence: Clinical features, treatment, and results in trials NHL-BFM 86 and 90

Medical and Pediatric Oncology

Volumn 35, Issue 1, 2000, Pages 20-27

  Neth, Olaf ^a   Seidemann, Kathrin ^a   Jansen, Petra ^a   Mann, Georg ^b   Tiemann, Markus ^c   Ludwig, Wolf Dieter ^d   Riehm, Hansjörg ^a   Reiter, Alfred ^e  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b ST ANNA CHILDREN S HOSPITAL   (Austria)

^c UNIVERSITY OF KIEL   (Germany)

^d HUMBOLDT UNIVERSITY   (Germany)

^e JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Childhood therapy; Lymphoblastic lymphoma; Precursor B cell

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; TIOGUANINE; VINCRISTINE;

ADOLESCENT; ARTICLE; CANCER CHEMOTHERAPY; CANCER REGRESSION; CANCER STAGING; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; FEMALE; FOLLOW UP; HUMAN; INFANT; LYMPHOBLASTOMA; MALE; PRIORITY JOURNAL; SKULL IRRADIATION; TREATMENT OUTCOME;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPARAGINASE; AUSTRIA; B-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DAUNORUBICIN; DISEASE-FREE SURVIVAL; FEMALE; GERMANY; HUMANS; INFANT; LYMPHOMA, LYMPHOBLASTIC; MALE; MULTICENTER STUDIES; NEOPLASM STAGING; PREDNISONE; PROSPECTIVE STUDIES; REGISTRIES; SURVIVAL ANALYSIS; VINCRISTINE;

EID: 0033949678     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-911X(200007)35:1<20::AID-MPO4>3.0.CO;2-L     Document Type: Article

References (37)

1. Picozzi VJ Jr, Coleman CN. Lymphoblastic lymphoma. Semin Oncol 1990;17:96-103.
2. Freedman AS, Nadler LM. Immunologic markers in non-Hodgkin's lymphoma. Hematol Oncol Clin North Am 1991;5: 871-898.
3. Reiter A, Schrappe M, Parwaresch, et al. Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage - a report of the Berlin-Frankfurt-Munster Group. J Clin Oncol 1995;13:359-372.
4. Borowitz MJ, Croker BP, Metzgar RS. Comparison of histologic and immunologic heterogeneity of non-Hodgkin's lymphomas. Am J Pathol 1981;105:97-106.
5. Cossman J, Chused TM, Fisher RI, et al. Diversity of immunological phenotypes of lymphoblastic lymphoma. Cancer Res 1983; 43:4486-4490.
6. Grogan T, Spier C, Wirt DP, et al. Immunologic complexity of lymphoblastic lymphoma. Diagn Immunol 1986;4:81-89.
7. Sheibani K, Nathwani BN, Winberg CD, et al. Antigenically defined subgroups of lymphoblastic lymphoma. Relationship to clinical presentation and biologic behavior. Cancer 1987;60:183-190.
8. Weiss LM, Bindl JM, Picozzi VJ. An immunophenotype study of 26 cases with comparison to T cell acute lymphoblastic leukemia. Blood 1986;67:474-478.
9. Brouet JC, Preud'homme JL, Penit C, et al. Acute lymphoblastic leukemia with pre-B-cell characteristics. Blood 1979;54:269-273.
10. Kamps WA, Poppema S. Pre-B-cell non-Hodgkin's lymphoma in childhood - report of a case and review of the literature. Am J Clin Pathol 1988; 90: 103-107.
11. Bene MC, Castoldi G, Knapp W, et al. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 1995;9:1783-1786.
12. Link MP, Shuster JJ, Donaldson SS, et al. Treatment of children with localized non Hodgkin's lymphoma (NHL) with nine weeks of chemotherapy without radiotherapy. Med Pediatr Oncol 1993; 21:532.
13. Gérard-Marchant H, Hamlin I, Lennert K, et al. Classification of non-Hodgkin's lymphoma. Lancet 1974;ii:406-408.
14. Stansfeld AG, Diebold J, Noel H, et al. Updated Kiel classification for lymphomas [letter; published erratum appears in Lancet 1988;i:372]. Lancet 1988;1:292-293.
15. Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol 1976;33:451-458.
16. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-580.
17. Cordell JL, Falini B, Erber WN, et al. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984;32:219-229.
18. Radzun HJ, Hansmann ML, Heidebrecht HJ, et al. Detection of a monocyte/macrophage differentiation antigen in routinely processed paraffin-embedded tissues by monoclonal antibody Ki-M1P. Lab Invest 1991;65:306-315.
19. Meister P, Huhn D, Nathrath W. Malignant histiocytosis. Immunohistochemical characterization on paraffin embedded tissue. Virchows Arch Pathol Anat 1980;385:233-246.
20. Ludwig WD, Bartram CR, Ritter J, et al. Ambiguous phenotypes and genotypes in 16 children with acute leukemia as characterized by multiparameter analysis. Blood 1988;71:1518-1528.
21. Murphy SB. Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lymphomas in adults. Semin Oncol 1980;7:332-339.
22. Reiter A, Schrappe M, Tiemann M, et al. Improved treatment results in childhood B-cell neoplasms with tailord intensification of therapy - a report of the Berlin-Frankfurt-Münster Group trial NHL-BFM 90. Blood 1999;94:3294-3306.
23. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
24. Greenwood M. The natural duration of cancer. Reports on public health and medical subjects 33. London: Her Majesty's Stationery Office; 1926. p 1-26.
25. Bührer A, Schrappe M, Fengler, et al. Peripheral blast counts at diagnosis of late isolated bone marrow relapse of childhood acute lymphoblastic leukemia predict response to salvage chemotherapy and outcome. Berlin-Frankfurt-Münster Relapse Study Group. J Clin Oncol 1996;14:2812-2817.
26. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361-1392.
27. Korsmeyer S, Hieter P, Ravetch J, et al. Development hierarchy of immunglobulin gene rearrangements in leukemic pre-B cells. Proc Natl Acad Sci USA 1981;78:7096-70100.
28. Korsmeyer S, Arnod A, Bakhshi A, et al. Immunglobulin gene rearrangement and cell surface antigen in acute lymphocytic leukemias of T-cell and B-cell precursor origins. J Clin Invest 1983; 71:301-313.
29. Reiter A, Schrappe M, Ludwig W-D, et al: Chemotherapy in 998 unselected acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood 1994; 84:3122-3133.
30. Link MP, Roper M, Dorfman RF, et al. Cutaneous lymphoblastic lymphoma with pre-B markers. Blood 1983;61:838-841.
31. Meyers L, Hakami N. Pre-B cell cutaneous lymphoma in infancy: a unique clinical entity. Med Pediatr Oncol 1984;12:252-254.
32. Grumayer ER, Ladenstein RL, Slave I, et al. B-cell differentiation pattern of cutaneous lymphomas in infancy and childhood. Cancer 1988;61:303-308.
33. Kawasaki H, Ito K, Matsushita T, et al. Primary non-Hodgkin's lymphoma of the skin in children. Acta Paediatr 1994;83:1315-1316.
34. Zaatari GS, Chan WC, Kim TH, et al. Malignant lymphoma of the skin in children. Cancer 1987;59:1040-1045.
35. Link MP, Shuster JS, Donaldson SS, et al. Treatment of children and young adults with early-stage Non-Hodgkin's lymphoma. N Engl J Med 1997;337:1259-1306.
36. Vezzoni P, Giardini R, Lucchini R, et al. Adenosine deamninase and terminal deoxynucleotidyl transferase in human lymphomas: an aid to the diagnosis and subclassification of lymphoblastic lymphoma. Am J Hematol 1985;19:219-227.
37. Riehm H, Gadner H, Henze G, et al. Results and significance of six randomized trials in four consecutive ALL-BFM studies. In: Büchner T, Schellong G, Hiddemann G, Ritter J, editors. Haematology and blood transfusion, acute leukemias II. Berlin, Heidelberg: Springer; 1990. p 439-449.